BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6666546)

  • 1. The influence of high-dose prednisone medication on autoantibody specific activity and on circulating immune complex level in cerebrospinal fluid of multiple sclerosis patients.
    Wajgt A; Górny MK; Jenek R
    Acta Neurol Scand; 1983 Dec; 68(6):378-85. PubMed ID: 6666546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immunosuppressive therapy on humoral immune response in multiple sclerosis.
    Wajgt A; Górny M; Szczechowski L; Grzybowski G; Ochudło S
    Acta Med Pol; 1989; 30(3-4):121-8. PubMed ID: 2485126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
    Wajgt A; Górny M
    Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to detect anti-MAG antibodies by RIA in CSF of patients with multiple sclerosis.
    Nobile-Orazio E; Spagnol G; Scarlato G
    J Neuroimmunol; 1986 Apr; 11(2):165-9. PubMed ID: 2419358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies against encephalitogenic protein and myelin glycoprotein in the cerebrospinal fluid of patients with multiple sclerosis. Effect of encorton treatment on the autoantibody and immune complex levels].
    Waigt A; Górny MK
    Folia Med Cracov; 1984; 25(3-4):307-18. PubMed ID: 6085729
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathecal IgG synthesis and autoantibody-secreting cells in multiple sclerosis.
    Sellebjerg F; Jensen CV; Christiansen M
    J Neuroimmunol; 2000 Aug; 108(1-2):207-15. PubMed ID: 10900355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.
    Warren KG; Catz I
    J Neurol Sci; 1994 Jan; 121(1):66-73. PubMed ID: 7510787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: cells secreting antibodies against myelin-associated glycoprotein are present in cerebrospinal fluid.
    Baig S; Olsson T; Yu-Ping J; Höjeberg B; Cruz M; Link H
    Scand J Immunol; 1991 Jan; 33(1):73-9. PubMed ID: 1705050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cells and antibodies in MS.
    Link H; Baig S; Jiang YP; Olsson O; Höjeberg B; Kostulas V; Olsson T
    Res Immunol; 1989 Feb; 140(2):219-26; discussion 245-8. PubMed ID: 2662285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal synthesis of anti-myelin basic protein IgG in HIV-1+ patients.
    Maimone D; Annunziata P; Cioni C; Leonardi A; Guazzi GC
    Acta Neurol Scand; 1994 Oct; 90(4):285-92. PubMed ID: 7530889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A myelin basic protein antibody cascade in purified IgG from cerebrospinal fluid of multiple sclerosis patients.
    Warren KG; Catz I
    J Neurol Sci; 1990 Apr; 96(1):19-27. PubMed ID: 1693669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis.
    Warren KG; Catz I; Johnson E; Mielke B
    Ann Neurol; 1994 Mar; 35(3):280-9. PubMed ID: 7510098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
    Kasai N; Pachner AR; Yu RK
    J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of autoantibodies to myelin basic protein by antigen specific affinity chromatography from cerebrospinal fluid IgG of multiple sclerosis patients. Immunoreactivity studies with human myelin basic protein.
    Warren KG; Catz I
    J Neurol Sci; 1991 May; 103(1):90-6. PubMed ID: 1713953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis.
    Warren KG; Catz I
    J Neuroimmunol; 1993 Mar; 43(1-2):87-96. PubMed ID: 7681451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal synthesis of autoantibodies to myelin basic protein in multiple sclerosis.
    Catz I; Warren KG
    Can J Neurol Sci; 1986 Feb; 13(1):21-4. PubMed ID: 2420428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between levels of cerebrospinal fluid myelin basic protein and IgG measurements in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1985 May; 17(5):475-80. PubMed ID: 2408558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.